TestlBankl-lPharmacology:lAlPatient-CenteredlNursinglProcesslApproachl(9thlEdition,l2017)
PHARMACOLOGYl9THlEDITIONlMCCUISTIONlTESTlBANK
Thislislalsetloflquestionsltolanswerlthelquestionslofltheltextbookl"Pharmacology:lAlPatient-
CenteredlNursinglProcesslApproachl9thlEdition"litlhelpslyoultolbetterlunderstandlthelbooklcorrectly.
GetlthelrightldosageloflpharmacologylcontentltolsucceedlonlthelNCLEXlandlaslalprofessionallnurselwithl"P
harmacology:lAlPatient-
CenteredlNursinglProcesslApproach,l9thlEdition".lUsinglalstreamlinedlprototypelapproachlandlanlempha
sislonlnursinglcare,lthisltextlmakeslitleasylforltoday’slnursinglstudentsltolbetterlunderstandlthelcomplicate
dlsubjectloflpharmacology.lThelbook’sldetailedlchapterlonldosagelcalculation,lthelnursinglprocesslframew
orklforldrugltherapy,lstronglQSENlfocus,landlsummariesloflprototypeldrugslhelpldeliverlthelperfect.
,TestlBankl-lPharmacology:lAlPatient-CenteredlNursinglProcesslApproachl(9thlEdition,l2017)
PHARMACOLOGYl9THlEDITIONlMCCUISTIONlTESTlBANK
Table of Contents
l l
TableloflContents Chapterl28:lPeptides,lAntimalarial,land
Chapterl01:lDruglDevelopmentlandlEthi Anthelmintic
callConsiderations Chapterl29:lHIV-landlAIDS-
Chapterl02:lPharmacokinetics,lPharma RelatedlDrugs
codynamics,landlPharmacogenetics Chapterl30:lTransplantlDrugsl
Chapterl03:lCulturallConsiderationslCh Chapterl31:lVaccineslChapterl
apterl04:lComplementarylandlAlternati 32:lAnticancerlDrugs
velTherapies Chapterl33:lTargetedlTherapiesltolTreatlCanc
Chapterl05:lPediatriclConsiderationsl er
Chapterl06:lGeriatriclConsiderationsl Chapterl34:lBiologiclResponselModifiers
Chapterl07:lDrugslinlSubstancelUselDi Chapterl35:lUpperlRespiratorylDisorder
sorder s
Chapterl08:lThelNursinglProcesslandlP Chapterl36:lLowerlRespiratorylDisorder
atient-CenteredlCare s
Chapterl09:lSafetylandlQualitylChapterl Chapterl37:lCardiaclGlycosides,lAntia
10:lDruglAdministrationlChapterl11:lDru nginals,landlAntidysrhythmicslChapterl
glCalculationslChapterl12:lFluidlVolum 38:lDiuretics
elandlElectrolytes Chapterl39:lAntihypertensive
Chapterl13:lVitaminlandlMinerallReplac Chapterl40:lAnticoagulants,lAntiplatelets
ement ,landlThrombolyticslChapterl41:lAntihype
Chapterl14:lNutritionallSupportlChapte rlipidemicslandlPeripherallVasodilators
rl15:lAdrenergiclAgonistslandlAntagonis Chapterl42:lGastrointestinallTractlDisor
ts ders
Chapterl16:lCholinergiclAgonistslandlA Chapterl43:lAntiulcerlDrugslChapterl
ntagonists 44:lEyelandlEarlDisorderslChapterl45
Chapterl17:lStimulants :lDermatologiclDisorderslChapterl46:l
Chapterl18:lDepressantslChapterl Pituitary,lThyroid,lParathyroid,landlA
19:lAntiseizurelDrugs drenallDisorderslChapterl47:lAntidia
Chapterl20:lDrugslforlParkinsonismlandlAl betics
zheimer'slDisease Chapterl48:lUrinarylDisorderslChapterl
Chapterl21:lDrugslforlNeuromuscularlDi 49:lPregnancylandlPretermlLabor
sorderslandlMusclelSpasmslChapterl2 Chapterl50:lLabor,lDelivery,landlPostpa
2:lAntipsychoticslandlAnxiolytics rtum
Chapterl23:lAntidepressantslandlMoodlSta Chapterl51:lNeonatallandlNewbornlC
bilizers hapterl52:lWomen'slReproductivelHe
Chapterl24:lAntiinflammatories alth
Chapterl25:lAnalgesics Chapterl53:lMen'slReproductivelHealthlCha
Chapterl26:lAntibacterials pterl54:lSexuallylTransmittedlInfections
Chapterl27:lAntituberculars,lAntifungals,la Chapterl55:lAdultlandlPediatric
ndlAntivirals
,TestlBankl-lPharmacology:lAlPatient-CenteredlNursinglProcesslApproachl(9thlEdition,l2017)
PHARMACOLOGYl9THlEDITIONlMCCUISTIONlTESTlBANK
EmergencylDrugs
, TestlBankl-lPharmacology:lAlPatient-CenteredlNursinglProcesslApproachl(9thlEdition,l2017)
PHARMACOLOGYl9THlEDITIONlMCCUISTIONlTESTlBANK
Chapter 01: Drug Development and Ethical Considerations
l l l l l l
MULTIPLElCHOICE
1. ThelnurselislpreparingltoladministerlalschedulelIIlinjectableldruglandlisldrawingluplhalfloflthelco
ntentsloflalSingle-uselvial.lWhichlnursinglactionlislcorrect?
a. Asklanotherlnurseltolobservelandlcosignlwastinglthelremainingldruglfromlthelvial.
b. Keeplthelremaininglamountlinlthelpatient’sldrawerltolgivelatlthelnextldose.
c. Recordlthelamountlunusedlinlthelpatient’slmedicationlrecord.
d. Disposeloflthelviallwithlthelremainingldruglintolallockedlcollectionlbox.lANS
:l A
SchedulelIIldrugslarelcontrolledlsubstances,landlalllmustlbelaccountedlfor.lW henlwastinglalportionlo
flaldrug,lanotherlnurselshouldlobservelandlcosignlthatlaldruglwaslwasted.
DIF:lCOGNITIVElLEVEL:lApplyingl(Application)lTO
P:lNURSINGlPROCESS:lNursinglIntervention
MSC:lNCLEX:lPhysiologicallIntegrity:lPharmacologicallandlParenterallTherapies
2. Alpatientlislprescribedlalmedicationlandlaskslthelnurselifltheldruglislavailablelinlalgenericlform.lT
helnurselunderstandslthatlalgenericlmedicationlwilllhavelalnamelthat
a. islalregisteredltrademark.
b. islalwayslcapitalized.
c. describesltheldrugslchemicallstructure.
d. islnon-
proprietary.lANS:lD
Thelgenericlnamelislthelofficial,lnon-
proprietarylnamelforlaldrug.lThelbrandlnamelisltheltrademarklnamelandlislalwayslcapitalized.lThelche
micallnameldescribeslthelchemicallstructurelofltheldrug.
DIF:lCOGNITIVElLEVEL:lUnderstandingl(Comprehension)lT
OP:lNURSINGlPROCESS:lN/A
MSC:lNCLEX:lPhysiologicallIntegrity:lPharmacologicallandlParenterallTherapies
3. Alpatientlreceiveslalprescriptionlonlwhichlthelproviderlhaslnotedlthatlalgenericlmedicationlmaylb
elgiven.Thelpatientlaskslthelnurselwhatlthislmeans.lWhatlwilllthelnurseltelllthelpatientlaboutlgeneri
cldrugs?
a. Theylcontainlthelsamelinertlingredientslaslbrand-nameldrugs.
b. Theylhavelchemicallstructureslthatlarelidenticalltolproprietaryldrugs.
c. Theyltendltolbellesslexpensivelthanlbrand-nameldrugs.
d. Theylundergolextensiveltestinglbeforeltheylarelmarketed.lA
NS:lC
GenericldrugslarelapprovedlbylthelFDAlifltheylarelprovedltolbelbioequivalentltolthelbrand-
lnameldrug.lTheyltendltolbellesslexpensivelbecauselmanufacturerslofltheseldrugsldolnotlhaveltoldolt
helextensiveltestinglrequiredloflbrand-
nameldrugslbeforelmarketing.lTheylarelnotlidenticalltolbrand-
nameldrugslandloftenlhaveldifferentlinertlingredients.
DIF:lCOGNITIVElLEVEL:lApplyingl(Application)
TOP:lNURSINGlPROCESS:lNursinglIntervention:lPatientlTeachinglMSC:l
NCLEX:lManagementloflClientlCare
4. ThelnurselreviewslinformationlaboutlaldruglandlnoteslthelinitialslUSPlafterltheldrugslofficiallname
.lThelnurselunderstandslthatlthisldesignationlindicatesltheldrug
a. islalcontrolledlsubstance.
PHARMACOLOGYl9THlEDITIONlMCCUISTIONlTESTlBANK
Thislislalsetloflquestionsltolanswerlthelquestionslofltheltextbookl"Pharmacology:lAlPatient-
CenteredlNursinglProcesslApproachl9thlEdition"litlhelpslyoultolbetterlunderstandlthelbooklcorrectly.
GetlthelrightldosageloflpharmacologylcontentltolsucceedlonlthelNCLEXlandlaslalprofessionallnurselwithl"P
harmacology:lAlPatient-
CenteredlNursinglProcesslApproach,l9thlEdition".lUsinglalstreamlinedlprototypelapproachlandlanlempha
sislonlnursinglcare,lthisltextlmakeslitleasylforltoday’slnursinglstudentsltolbetterlunderstandlthelcomplicate
dlsubjectloflpharmacology.lThelbook’sldetailedlchapterlonldosagelcalculation,lthelnursinglprocesslframew
orklforldrugltherapy,lstronglQSENlfocus,landlsummariesloflprototypeldrugslhelpldeliverlthelperfect.
,TestlBankl-lPharmacology:lAlPatient-CenteredlNursinglProcesslApproachl(9thlEdition,l2017)
PHARMACOLOGYl9THlEDITIONlMCCUISTIONlTESTlBANK
Table of Contents
l l
TableloflContents Chapterl28:lPeptides,lAntimalarial,land
Chapterl01:lDruglDevelopmentlandlEthi Anthelmintic
callConsiderations Chapterl29:lHIV-landlAIDS-
Chapterl02:lPharmacokinetics,lPharma RelatedlDrugs
codynamics,landlPharmacogenetics Chapterl30:lTransplantlDrugsl
Chapterl03:lCulturallConsiderationslCh Chapterl31:lVaccineslChapterl
apterl04:lComplementarylandlAlternati 32:lAnticancerlDrugs
velTherapies Chapterl33:lTargetedlTherapiesltolTreatlCanc
Chapterl05:lPediatriclConsiderationsl er
Chapterl06:lGeriatriclConsiderationsl Chapterl34:lBiologiclResponselModifiers
Chapterl07:lDrugslinlSubstancelUselDi Chapterl35:lUpperlRespiratorylDisorder
sorder s
Chapterl08:lThelNursinglProcesslandlP Chapterl36:lLowerlRespiratorylDisorder
atient-CenteredlCare s
Chapterl09:lSafetylandlQualitylChapterl Chapterl37:lCardiaclGlycosides,lAntia
10:lDruglAdministrationlChapterl11:lDru nginals,landlAntidysrhythmicslChapterl
glCalculationslChapterl12:lFluidlVolum 38:lDiuretics
elandlElectrolytes Chapterl39:lAntihypertensive
Chapterl13:lVitaminlandlMinerallReplac Chapterl40:lAnticoagulants,lAntiplatelets
ement ,landlThrombolyticslChapterl41:lAntihype
Chapterl14:lNutritionallSupportlChapte rlipidemicslandlPeripherallVasodilators
rl15:lAdrenergiclAgonistslandlAntagonis Chapterl42:lGastrointestinallTractlDisor
ts ders
Chapterl16:lCholinergiclAgonistslandlA Chapterl43:lAntiulcerlDrugslChapterl
ntagonists 44:lEyelandlEarlDisorderslChapterl45
Chapterl17:lStimulants :lDermatologiclDisorderslChapterl46:l
Chapterl18:lDepressantslChapterl Pituitary,lThyroid,lParathyroid,landlA
19:lAntiseizurelDrugs drenallDisorderslChapterl47:lAntidia
Chapterl20:lDrugslforlParkinsonismlandlAl betics
zheimer'slDisease Chapterl48:lUrinarylDisorderslChapterl
Chapterl21:lDrugslforlNeuromuscularlDi 49:lPregnancylandlPretermlLabor
sorderslandlMusclelSpasmslChapterl2 Chapterl50:lLabor,lDelivery,landlPostpa
2:lAntipsychoticslandlAnxiolytics rtum
Chapterl23:lAntidepressantslandlMoodlSta Chapterl51:lNeonatallandlNewbornlC
bilizers hapterl52:lWomen'slReproductivelHe
Chapterl24:lAntiinflammatories alth
Chapterl25:lAnalgesics Chapterl53:lMen'slReproductivelHealthlCha
Chapterl26:lAntibacterials pterl54:lSexuallylTransmittedlInfections
Chapterl27:lAntituberculars,lAntifungals,la Chapterl55:lAdultlandlPediatric
ndlAntivirals
,TestlBankl-lPharmacology:lAlPatient-CenteredlNursinglProcesslApproachl(9thlEdition,l2017)
PHARMACOLOGYl9THlEDITIONlMCCUISTIONlTESTlBANK
EmergencylDrugs
, TestlBankl-lPharmacology:lAlPatient-CenteredlNursinglProcesslApproachl(9thlEdition,l2017)
PHARMACOLOGYl9THlEDITIONlMCCUISTIONlTESTlBANK
Chapter 01: Drug Development and Ethical Considerations
l l l l l l
MULTIPLElCHOICE
1. ThelnurselislpreparingltoladministerlalschedulelIIlinjectableldruglandlisldrawingluplhalfloflthelco
ntentsloflalSingle-uselvial.lWhichlnursinglactionlislcorrect?
a. Asklanotherlnurseltolobservelandlcosignlwastinglthelremainingldruglfromlthelvial.
b. Keeplthelremaininglamountlinlthelpatient’sldrawerltolgivelatlthelnextldose.
c. Recordlthelamountlunusedlinlthelpatient’slmedicationlrecord.
d. Disposeloflthelviallwithlthelremainingldruglintolallockedlcollectionlbox.lANS
:l A
SchedulelIIldrugslarelcontrolledlsubstances,landlalllmustlbelaccountedlfor.lW henlwastinglalportionlo
flaldrug,lanotherlnurselshouldlobservelandlcosignlthatlaldruglwaslwasted.
DIF:lCOGNITIVElLEVEL:lApplyingl(Application)lTO
P:lNURSINGlPROCESS:lNursinglIntervention
MSC:lNCLEX:lPhysiologicallIntegrity:lPharmacologicallandlParenterallTherapies
2. Alpatientlislprescribedlalmedicationlandlaskslthelnurselifltheldruglislavailablelinlalgenericlform.lT
helnurselunderstandslthatlalgenericlmedicationlwilllhavelalnamelthat
a. islalregisteredltrademark.
b. islalwayslcapitalized.
c. describesltheldrugslchemicallstructure.
d. islnon-
proprietary.lANS:lD
Thelgenericlnamelislthelofficial,lnon-
proprietarylnamelforlaldrug.lThelbrandlnamelisltheltrademarklnamelandlislalwayslcapitalized.lThelche
micallnameldescribeslthelchemicallstructurelofltheldrug.
DIF:lCOGNITIVElLEVEL:lUnderstandingl(Comprehension)lT
OP:lNURSINGlPROCESS:lN/A
MSC:lNCLEX:lPhysiologicallIntegrity:lPharmacologicallandlParenterallTherapies
3. Alpatientlreceiveslalprescriptionlonlwhichlthelproviderlhaslnotedlthatlalgenericlmedicationlmaylb
elgiven.Thelpatientlaskslthelnurselwhatlthislmeans.lWhatlwilllthelnurseltelllthelpatientlaboutlgeneri
cldrugs?
a. Theylcontainlthelsamelinertlingredientslaslbrand-nameldrugs.
b. Theylhavelchemicallstructureslthatlarelidenticalltolproprietaryldrugs.
c. Theyltendltolbellesslexpensivelthanlbrand-nameldrugs.
d. Theylundergolextensiveltestinglbeforeltheylarelmarketed.lA
NS:lC
GenericldrugslarelapprovedlbylthelFDAlifltheylarelprovedltolbelbioequivalentltolthelbrand-
lnameldrug.lTheyltendltolbellesslexpensivelbecauselmanufacturerslofltheseldrugsldolnotlhaveltoldolt
helextensiveltestinglrequiredloflbrand-
nameldrugslbeforelmarketing.lTheylarelnotlidenticalltolbrand-
nameldrugslandloftenlhaveldifferentlinertlingredients.
DIF:lCOGNITIVElLEVEL:lApplyingl(Application)
TOP:lNURSINGlPROCESS:lNursinglIntervention:lPatientlTeachinglMSC:l
NCLEX:lManagementloflClientlCare
4. ThelnurselreviewslinformationlaboutlaldruglandlnoteslthelinitialslUSPlafterltheldrugslofficiallname
.lThelnurselunderstandslthatlthisldesignationlindicatesltheldrug
a. islalcontrolledlsubstance.
